504 related articles for article (PubMed ID: 22146604)
1. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease.
Wingerchuk DM; Weinshenker BG
Mult Scler; 2012 Jan; 18(1):5-10. PubMed ID: 22146604
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica and non organ-specific autoimmunity.
Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
[TBL] [Abstract][Full Text] [Related]
3. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
[TBL] [Abstract][Full Text] [Related]
4. [Differential diagnosis of neuromyelitis optica spectrum disorders].
Tanaka K; Tanaka M
Brain Nerve; 2010 Sep; 62(9):953-60. PubMed ID: 20844306
[TBL] [Abstract][Full Text] [Related]
5. A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica.
Iyer A; Elsone L; Appleton R; Jacob A
Autoimmunity; 2014 May; 47(3):154-61. PubMed ID: 24512514
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
Mehta LR; Samuelsson MK; Kleiner AK; Goodman AD; Anolik JH; Looney RJ; Schwid SR
Mult Scler; 2008 Apr; 14(3):425-7. PubMed ID: 18208886
[TBL] [Abstract][Full Text] [Related]
7. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?
Niţescu D; Nicolau A; Caraiola S; Predeţeanu D; Ionescu R; Tănăsescu C
Rom J Intern Med; 2011; 49(4):295-300. PubMed ID: 22568275
[TBL] [Abstract][Full Text] [Related]
10. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
11. Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica.
Pereira WLCJ; Reiche EMV; Kallaur AP; Oliveira SR; Simão ANC; Lozovoy MAB; Schiavão LJV; Rodrigues PRDVP; Alfieri DF; Flauzino T; Kaimen-Maciel DR
Acta Neuropsychiatr; 2017 Jun; 29(3):170-178. PubMed ID: 27692000
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
13. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
[TBL] [Abstract][Full Text] [Related]
15. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
Jordan B; Eger K; Kornhuber ME; Zierz S
Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
[TBL] [Abstract][Full Text] [Related]
16. [European treatment recommendation of neuromyelitis optica spectrum disorders: critical remarks and case discussion].
Kőszegi E; Illés Z
Ideggyogy Sz; 2012 May; 65(5-6):201-6. PubMed ID: 22724289
[TBL] [Abstract][Full Text] [Related]
17. Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases.
Dellavance A; Alvarenga RR; Rodrigues SH; Kok F; de Souza AW; Andrade LE
Eur J Neurol; 2012 Feb; 19(2):248-52. PubMed ID: 21771203
[TBL] [Abstract][Full Text] [Related]
18. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
Asgari N; Skejø HP; Lillevang ST; Stenager E
Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
Wu L; Yang Y; Huang DH; Wu WP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
